Table 2.
Average statistics of MM-PBSA calculation
| MMPBSA | |||||
|---|---|---|---|---|---|
| Protein–ligand complexes | ΔEMM (kJ mol–1) | ΔGSol (kJ mol–1) | ΔGBind (kJ mol–1) | ||
| ΔEVdW (kJ mol–1) | ΔEElec (kJ mol–1) | ΔGPB (kJ mol–1) | ΔGSASA (kJ mol–1) | ||
| N3–SARS-CoV-2 Mpro | − 361.67 ± 33.14 | − 50.54 ± 21.37 | 158.36 ± 26.85 | − 29.11 ± 1.95 | − 282.96 ± 32.97 |
| ECG–SARS-CoV-2 Mpro | − 275.01 ± 18.68 | − 76.97 ± 29.45 | 179.86 ± 30.32 | − 20.28 ± 1.11 | − 192.40 ± 27.10 |
ΔEVdW Van der Waals contribution from MM, ΔEElec electrostatic energy as calculated by the MM force field, ΔGSol solvation free energy comprising ΔGPB, the polar (ΔGpolar) and non-polar (ΔGnon-polar) solvation free energy contribution calculated by PB equation, ΔGSASA the energy contribution from solvent-accessible surface area (SASA), ΔGBind binding free energy